-
ESMO 2024 | Dr. Gabriella Pravettoni: Physical Activity is Beneficial for Cancer Patients, But Also Challenging
Evidence from the Breast Cancer Customization Project suggests that a more comprehensive approach is needed to help patients find the motivation to adopt an active lifestyle. Physical activity is often recommended by clinicians as a lifestyle intervention to help prevent and manage non-communicable diseases, including cancer. It is also essential for the quality of life…
-
CCML 2024丨Dr. Xiaoling Ma: Setting Standards, Leveraging Technology, and Advancing Clinical Microbiology Testing Quality Across China
Infectious Disease Frontier: What do you think are the key highlights of this year’s CCML conference, and how do you believe they will positively influence clinical microbiology testing and infectious…
-
Gastroenterology丨Dr. Chuanlong Zhu: Analysis of a Rare Cause of Long-term Abnormal Liver Function in a Male Patient
Three pathogenic mutation sites in the SLC10A1 gene have been reported, among which c.800C＞T (p.Ser267Phe) is the most common mutation in China. This mutation significantly reduces the expression of sodium…
-
Dr. Yonghong Xiao: Responsibilities and Capacity Building of Infectious Disease Physicians
1. Infectious Diseases Infectious diseases are illnesses caused by pathogens, which include contagious and non-contagious diseases. Contagious diseases are defined as those caused by pathogens that have the potential to…
-
ESMO China’s Voice丨Dr. Jian Li’s Team Reports on Long-Term Follow-Up of the INTRIGUE China Bridging Study
Gastrointestinal stromal tumors (GIST) are mesenchymal tumors driven by mutations in oncogenes. In recent years, various types of small-molecule tyrosine kinase inhibitors (TKIs) have provided new treatment options for patients with advanced GIST, but there remains a significant unmet need in clinical care. During the 2024 ESMO Annual Meeting, Dr. Jian Li’s team from Peking…
-
ESMO Global Perspective | Prof. Xichun Hu, Prof. Linda, Prof. Esteller, and Prof. Qinghua Xu: New Advances in CUP Treatment and Prospects
With the rapid development of genetic testing technology, the treatment strategies for patients with cancer of unknown primary (CUP) are undergoing revolutionary changes. During the 2024 ESMO Congress, the World CUP Alliance held a special “Roundtable on Access & Awareness of Precision Oncology” at the ESMO Congress, looking forward to the current treatment of CUP…
-
ESMO 2024 | Dr. Maria-Alice Franzoi: Breastfeeding After Breast Cancer is Safe and Feasible
New data shows that breastfeeding does not increase the risk of breast cancer recurrence or developing secondary breast cancer, nor does it pose any health risks to the child.
-
ESMO 2024 | President Dr. Andrés Cervantes: From Precision Oncology to Molecular Prevention—A New Role for Our Profession?
With the rapid advancement of science and technology, there is growing hope that more cancers can be intercepted at their earliest stages. The European Society for Medical Oncology (ESMO) is deeply exploring the field of prevention to ensure that oncologists are educated and guided in this evolving area.
Connecting Medical Expertise through Media